Clinical Trial Update: Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two dosing regimens of micafungin to caspofungin for esophageal candidiasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Candidiasis
• Oropharyngeal Candidiasis

Drugs mentioned

• Caspofungin (caspofungin)
• Micafungin (micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Candidiasis, Oral | Phase 3 | Status: COMPLETED